Uncategorized

Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment, according to a Cancer Research UK funded study published on Monday in Nature Immunology. Researchers at the University of Southampton and La Jolla Institute for Allergy & Immunology, California, found that lung cancer patients with large amounts of a particular type of immune T-cell, called tissue-resident memory T-cells, in their tumour were 34 per cent less likely to die. The study also found that it was not just the numbers of cells that increased survival, but the cells’ behaviour played a key role. The cells clustered together and ‘took up residency’ in a particular tissue, in this case the cancer tissue, to protect the patient.

See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2017-06-19-discovery-could-guide-immunotherapy-for-lung-cancer